Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Latest predictions
€15.00
28.12.20
buy
-
10.09.20
€11.00
10.05.20
buy
€9.50
05.11.19
buy
€11.73
04.08.19
buy
€13.53
11.05.19
buy
Your prediction

General Electric Co. Stock

The price for the General Electric Co. stock decreased slightly today. Compared to yesterday there is a change of -€0.086 (-0.900%).
With 8 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
With a target price of €14.00 there is a positive potential of 47.306% for General Electric Co. compared to the current price of €9.50.
So far the community has only identified positive things for General Electric Co. stock. The most positive votes were given for criterium "Debt".

Pros and Cons of General Electric Co. in the next few years

Pros
1
Normal challenges to pay loans and raise capital
1
Revenue growth >5% per year expected
1
Could be worthwhile Investment >10% per year
Cons
0
-

Performance of General Electric Co. vs. its peers

Security Change (%) 1w 1m 1y YTD 3y 5y
General Electric Co. -0.900% 4.330% 7.608% -11.253% 11.008% -37.646% -64.216%
3M Company -0.530% -1.084% -3.958% -16.008% -3.877% -31.920% 4.794%
Illinois Tool Works -1.010% -0.996% 2.787% 5.221% 3.126% 19.787% 121.363%
Honeywell International -0.080% -1.004% -1.606% 5.810% 0.551% 31.969% 91.049%

Comments

Buy General Electric Co.

Buy General Electric Co.

Published 08.11.19
Prediction Buy
Perf. (%) -41.63%
Target price 10.410
Change

Buy with target price 10.41

Other discussions about General Electric Co. Stock

Trading General Electric Co.

Trading General Electric Co.

New thread Forum

News

GE Healthcare, GenesisCare Partner to Tackle Two Biggest Health Burdens Globally, Deliver Improved Cancer and Cardiovascular Care to Patients Around the Worldhttp://upload.wikimedia.org/wikipedia/commons/e/e4/General_electric.jpg: Thomas Edison [Public domain], via Wikimedia Commons
GE Healthcare, GenesisCare Partner to Tackle Two Biggest Health Burdens Globally, Deliver Improved Cancer and Cardiovascular Care to Patients Around the World


GE Healthcare, the leading global provider of advanced medical imaging, and GenesisCare, a leading provider of integrated cancer care globally and cardiovascular care in Australia, today announced

GE Digital 2020 User Conference: From Resilience to Innovationhttp://upload.wikimedia.org/wikipedia/commons/e/e4/General_electric.jpg: Thomas Edison [Public domain], via Wikimedia Commons
GE Digital 2020 User Conference: From Resilience to Innovation


GE Digital today begins a three-day virtual User Conference featuring stories of companies in multiple industries on their path to digital transformation: enabling more renewable energy on the

GE Healthcare’s Clariscan™ (gadoterate meglumine) Becomes Only FDA-Approved MRI Contrast Agent Available in Polymer Bottle


GE Healthcare’s innovative shatterproof polymer +PLUSPAK Pharmacy Bulk Package has been approved by the US FDA for use with its macrocyclic gadolinium-based MRI contrast agent, Clariscan